PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

BIOMARKER COMPOSITIONS, PROTEIN PANELS, DEVICES, AND METHODS TO IDENTIFY RISK OF AND TREAT PULMONARY VASCULAR INADEQUACY IN SINGLE VENTRICLE HEART DISEASE

METHOD FOR DETERMINING THE THERAPEUTIC REGIMEN FOR AN INDIVIDUAL AND ITS USE

TROPNIN MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION

HDL-ASSOCIATED PROTEIN BIOMARKER PANEL DETECTION

METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS

ASSAY METHODS, ASSAY CARTRIDGES, AND ASSAY DEVICES INCLUDING MAGNETIC PARTICLE DE-AGGREGATION

MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE

CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION

ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T

RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I

METHOD FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION

DIAGNOSTIC METHODS FOR CARDIOVASCULAR DISEASES

Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB

LOCKED APTAMER HAIRPIN INTEGRATED HYBRIDIZATION CHAIN REACTION FOR RAPID, INSTRUMENT-FREE BIOMARKER DETECTION

LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE

Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements

Cardiovascular Disease

Aptamer for specifically recognizing soluble ST2 protein and application of the same

PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

CERAMIDES AND THEIR USE IN DIAGNOSING CVD

METHOD OF PROGNOSIS

MASS SPECTROMETRY SAMPLE PROCESSING METHODS, CHROMATOGRAPHY DEVICES, AND DATA ANALYSIS TECHNIQUES FOR BIOMARKER ANALYSIS

Highly Sensitive System and Method for Analysis of Troponin

Device and method for detection of analytes

METHOD FOR PROGNOSIS

MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS

NOVEL BIOMARKER OF ACUTE CORONARY SYNDROMES

Diagnostic methods for cardiovascular diseases

USE OF MICRO-RNA TO IMPROVE AND TREAT CHRONIC PHASE CARDIAC FUNCTION

APPLICATION OF THBS1 PROTEIN AND THBS3 PROTEIN AS BIOMARKERS FOR DETECTING ACUTE MYOCARDIAL INFARCTION

AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS

METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASE DETECTION AND MANAGEMENT

Three-dimensional hydrogel-graphene-based biosensor and preparation method thereof

DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS

Cardiovascular Risk Event Prediction and Uses Thereof

USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE

APPLICATIONS OF SERUM S100A8/A9 COMPLEX LEVEL IN PROGNOSIS ASSESSMENT OF ACUTE MYOCARDIAL INFARCTION

Blood RNA biomarkers of coronary artery disease

METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS

Ceramides and their use in diagnosing CVD

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

REAL-TIME METHODS TO ENABLE PRECISION-GUIDED CPR TO IMPROVE NEUROLOGICAL OUTCOME AND PREDICT BRAIN DAMAGE AFTER ISCHEMIC INJURY AND REPERFUSION

Marker for diagnosing atherosclerosis severity, and diagnostic method using same

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

Recombinant antibody against human cardiac troponin I

Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

Lipidomic biomarkers for identification of high-risk coronary artery disease patients

DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS

HDL-ASSOCIATED PROTEIN BIOMARKER PANEL DETECTION

NMR measurements of NMR biomarker GlycA

Diagnostic methods for cardiovascular diseases

Nanovesicles derived from bacteria of genus and use thereof

Compositions and methods relating to a C-terminal peptide of troponin i with activity as a myofilament CA2+ desensitizer

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure

BIOMARKER PREDICTING CORONARY ARTERY DISEASES

Device and method for detection of analytes

Highly Sensitive System and Method for Analysis of Troponin

USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE

METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT

METHOD OF PROGNOSIS

Method of treating acute coronary syndrome

Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies

Podocan as a Predictive Biomarker of Cardiovascular Events

Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers

EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA

DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof

BNP (1-32) epitope and antibodies directed against said epitope

METHODS FOR PREVENTING, MODULATING AND/OR REDUCING CARDIOVASCULAR DISEASE

DUAL RANGE CARDIAC TROPONIN IMMUNOASSAY DEVICES AND METHODS USING IMMUNOSENSOR AND MAGNETIC IMMUNOSENSOR

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK

Test apparatus and methods for ST2 cardiac biomarker

Hough transform-based vascular network disorder features on baseline fluorescein angiography scans predict response to anti-VEGF therapy in diabetic macular edema

Lipidomic biomarkers for identification of high-risk coronary artery disease patients

BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE

Diagnostic and prognostic methods for cardiovascular diseases and events

Methods for detecting cardiac damage

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

Procalcitonin for the prognosis of adverse events

Method for predicting severity and prognosis of cardiovascular disease

ONE STEP CARDIAC TEST DEVICE

Methods and kits for the diagnosis and risk stratification of patients with ischemia

Ceramides and their use in diagnosing CVD

Ceramides for evaluating risk of cardiovascular disease

SIGNAL BIOMARKERS

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD

ASSAYS FOR MEASURING BINDING KINETICS AND BINDING CAPACITY OF ACCEPTORS FOR LIPOPHILIC OR AMPHIPHILIC MOLECULES

Medical use of CREG protein

METHOD FOR EARLY DIAGNOSING AND TREATING ACUTE CORONARY SYNDROME

Methods of detecting, diagnosing, and treating carotid plaque vulnerability

MARKERS FOR CORONARY ARTERY DISEASE AND USES THEREOF

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

USE OF CD146 AS A MARKER OF THE VASCULAR WALL TENSION

Methods of detection and treatment for cardiovascular disease and foot wounds

Circulating antibodies against MAA adducts as biomarker for coronary artery disease

Cartridge for diagnostic testing

Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

Device and method for detection of analytes

METHODS FOR THE DETECTION AND MONITORING OF VASCULAR INFLAMMATION

Multiple hybrid immunoassay

Biomarkers of myocardial injury

IL1RL-1 as a cardiovascular disease marker and therapeutic target

USES OF LP-PLA2 IN COMBINATION TO ASSESS CORONARY RISK

Biomarkers Related to Insulin Resistance Progression and Methods Using the Same

Method for identifying subjects with increased risk of ST-segment elevation myocardial infarction (STEMI) and identifying subjects likely to respond to particular treatments

MONOCYTE INTEGRIN BASED MICROFLUIDIC ASSAY FOR EVALUATING CORONARY DISEASES

Future cardiac event biomarkers CCL3, CCL5, and CCL18

Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor

METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE

Kit for diagnosis of coronary heart disease using multi-metabolites and clinical parameters, and method for diagnosis of coronary heart disease using the same

Highly Sensitive System and Methods for Analysis of Troponin

Method of differentiating stable angina pectoris from acute coronary syndrome and diagnostic kit thereof

COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT

Lipidomic biomarkers for identification of high-risk coronary artery disease patients

Biomarkers

Methods for detecting cardiac damage

HDL-associated protein biomarker panel detection

MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS

Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs

Disease prevention and alleviation by human myoblast transplantation

BIOMARKERS AND METHODS OF PREDICTION

Diagnostic of Obliterative Arteriopathies

Decision tree based systems and methods for estimating the risk of acute coronary syndrome

METABOLIC BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF STABLE ANGINA PECTORIS AND ACUTE CORONARY SYNDROME

Markers Associated With Arteriovascular Events And Methods Of Use Thereof

BIOMARKER COMPOSITIONS SPECIFIC TO CORONARY HEART DISEASE PATIENTS AND USES THEREOF

Kit for rapidly testing myocardial infarction and a preparation method and an application thereof

Methods for predicting and treating myocardial damage

Cartridge for diagnostic testing

Use of ceramides and LPLs in diagnosing CVD

Highly sensitive system and method for analysis of troponin

DETECTION, MONITORING AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements

Biomarkers for diagnosing ischemia

Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

BNP (1-32) epitope and antibodies directed against said epitope

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE

BIOMARKER TEST FOR ACUTE CORONARY SYNDROME

NMR measurements of NMR biomarker GlycA

LIPIDOMIC BIOMARKERS FOR THE PREDICTION OF CARDIOVASCULAR OUTCOMES IN CORONARY ARTERY DISEASE PATIENTS UNDERGOING STATIN TREATMENT

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

Method for determining FXIII levels as a prognostic biomarker in acute myocardial infarction

BIOMARKERS FOR CARDIOVASCULAR DISEASE

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

Biomarkers for epicardial adipose tissue

COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT

DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK

METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS

Multi-metabolites platform for diagnosis of acute coronary syndrome

Method for isolating apoptotic bodies

Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules

Ceramides and their use in diagnosing CVD

Relevance of achieved levels of markers of systemic inflammation following treatment

Methods for detecting cardiac damage

METHODS OF DIAGNOSING ACUTE CARDIAC DISORDERS USING BNP-SP

Assessing renal structural alterations and outcomes

A METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT

Myeloperoxidase, a risk indicator for cardiovascular disease

MYELOPEROXIDASE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE

Myeloperoxidase, a risk indicator for cardiovascular disease

Highly sensitive system and method for analysis of troponin

Blood based biomarkers for diagnosing atherosclerotic coronary artery disease

Predicting coronary artery disease and risk of cardiovascular events

Methods and kits for predicting the risk of having a cardiovascular disease or event

Test apparatus and methods for ST2 cardiac biomarker

DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1

DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK

Method for risk stratification in stable coronary artery disease

In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient

COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE

Multiple hybrid immunoassay

Fluorescence immunoassay sensor chip and fluorescence immunoassay method

Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies

Myeloperoxidase, a risk indicator for cardiovascular disease

FATTY ACID PATTERN ANALYSIS FOR PREDICTING ACUTE CORONARY SYNDROME

FUTURE CARDIAC EVENT BIOMARKERS

METHODS FOR ASSESSING THE RISK OF CARDIOVASCULAR DISEASE

Use of ACY-1 as a marker of ischaemia/reperfusion, delayed graft function and graft viability as well as method thereof

Lipidomic biomarkers for identification of high-risk coronary artery disease patients

Method of predicting survival time in myocardial infarction patients by measuring BAFF levels

FATTY ACID PATTERN ANALYSIS FOR PREDICTING ACUTE CORANARY SYNDROME

Ceramides and their use in diagnosing CVD

Biomarkers related to insulin resistance progression and methods using the same

Signal biomarkers

FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK

Markers associated with arteriovascular events and methods of use thereof

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor

ASSESSING RENAL STRUCTURAL ALTERATIONS AND OUTCOMES

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

Plasma HS levels as biomarkers for vascular disease

Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject

COMPLEX COMPRSING BEAD PARTICLE INCLUDING QUANTUM DOT LAYER AND METHOD OF DIAGNOSING MYOCARDIAL INFARCTION-RELATED DISEASE BY USING THE COMPLEX

Method for detection of IGFBP-4 fragments

Diagnostic method of cardiovascular disease

METHODS OF DIAGNOSIS AND RISK STRATIFICATION OF ADVERSE EVENTS IN POST MYOCARDIAL INFARCTION PATIENTS USING PRO-ADRENOMEDULLIN

Combined F2-isoprostane and myleoperoxidase detection, a risk indicator for cardiovascular disease

Methods for treatment of cardiovascular disease

COMPOSITIONS AND METHODS FOR ASSESSING CARDIOVASCULAR DISEASE

1L1RL-1 as a cardiovascular disease marker and therapeutic target

IDENTIFICATION OF SPECIFIC APOLIPOPROTEIN EPITOPES ON CIRCULATING ATHEROGENIC LOW-DENSITY LIPOPROTEIN

BAG3 as biochemical serum and tissue marker

Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity C-reactive protein

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

COMPOSITIONS AND METHODS FOR TREATING CARDIAC HYPERTROPHY

Method for evaluating ischemic heart disease by assaying complement factor H or D

METHODS AND KITS FOR PREDICTING THE RISK OF HAVING A CARDIOVASCULAR EVENT IN A SUBJECT

Method for risk stratification in stable coronary artery disease

METHODS FOR PREDICTING CARDIOVASCULAR EVENTS AND MONITORING TREATMENT USING PCSK9

Fractional C-reactive protein (fracCRP) antibodies and assays

Device and method for detection of analytes

Biomarkers for diagnosing ischemia

Methods for detecting cardiac damage

Oxidized cardiolipin as a pro-inflammatory factor

DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK

Means and methods for recognizing the development of cardiovascular disease in an individual

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment

Granzyme A and granzyme B diagnostics

Method for monitoring, diagnosis and/or prognosis of hypoxia related disorders using NFAT5

Peptide biomarkers of cardiovascular disease

Method for diagnosis, prognosis or treatment of acute coronary syndrome (ACS) comprising measurement of plasma concentration of macrophage migration inhibitory factor (MIF)

Biomarkers for myocardial ischemia

Cartridge for diagnostic testing

Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease

Combination for early exclusion of acute myocardial infarction

Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II

URINARY sCD14 AS A BIOMARKER FOR CORONARY ARTERY DISEASE

Nitrated cardiac troponin I as a biomarker of cardiac ischemia

Methods, kits and systems for signal amplification for bioassays using zinc nanoparticles

Methods for treatment of cardiovascular disease

Highly sensitive system and method for analysis of troponin

Lipidomic biomarkers for identification of high-risk coronary artery disease patients

Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method

Reagent and reagent kit for measurement of FDP, and measurement method

Methods for the detection and monitoring of acute myocardial infarction

Methods and devices for diagnosing cardiac disorders

ANTIBODIES, COMPOSITIONS, AND ASSAYS FOR DETECTION OF CARDIAC DISEASE

ANTIBODIES, COMPOSITIONS, AND ASSAYS FOR DETECTION OF CARDIAC DISEASE

GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

TROPONIN BASED RULE-IN AND RULE-OUT ALGORITHM OF MYOCARDIAL INFARCTION

Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof

METHODS FOR ASSESSING THE RISK OF CARDIOVASCULAR DISEASE

CARDIOVASCULAR AUTOIMMUNE DISEASE PANEL AND METHODS OF USING SAME

METHODS AND ASSAYS FOR RISK PREDICTION, DIAGNOSIS, AND ANALYSIS OF MYOCARDIAL INFARCTION, HEART FAILURE AND REDUCED CARDIAC FUNCTION

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

METHOD FOR DIAGNOSING ACUTE CORONARY SYNDROME

Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction

Method for screening of therapeutic agent for hyperlipemia

METHODS OF PREDICTING AND TREATING ADVERSE CARDIAC EVENTS

Method for Detecting Cardiac Ischemia via Changes in B-Natriuretic Peptide Levels

METHODS AND COMPOSITIONS FOR DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION (AMI)

Treatment of cardiovascular disease and thrombosis

Diagnostic kit for IGFBP-4 proteolytic fragments in a patient sample

Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques

CMYBP-C and MLC2 as diagnostic markers of cardiac injury

PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS

DIAGNOSTIC AND PROGNOSTIC ASSAY

Diagnosis of restenosis in patients undergoing percutaneous coronary intervention

DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP

MEANS AND METHODS FOR RECOGNIZING THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN AN INDIVIDUAL

Method for risk stratification in stable coronary artery disease

WHOLE BLOOD ASSAY OF AN INTRACELLULAR BIOMARKER OF A CELL SIGNALLING PATHWAY USE IN MEASURING THE ACTIVATION OF A PREDETERMINED CELL POPULATION

Method of Detecting Major In-Hospital Ischemic Complications and Predicting Length of Stay at an Intensive Care Unit

METHOD AND APPARATUS FOR ANALYZING VITAMIN E IN LIPOPROTEINS

Signal biomarkers

Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy

PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS

GALECTIN-3 AND STATIN THERAPY

METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA

METHOD TO DETECT AND MONITOR COMPARTMENT SYNDROME

Biomarkers for myocardial ischemia

METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS

BIOMARKER FOR THE PREDICTION OF FIRST ADVERSE EVENTS

PREDICTING CORONARY ARTERY DISEASE AND RISK OF CARDIOVASCULAR EVENTS

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

MYELOPEROXIDASE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE

Methods for treatment of cardiovascular disease

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

Assay for Troponin I using magnetic labels

IL1RL-1 as a cardiovascular disease marker and therapeutic target

Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor

AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES

USE OF CARDIAC HORMONES TO ASSESS RISK OF CARDIOVASCULAR COMPLICATION FROM VOLUME OVERLOAD

IMMUNOASSAYS FOR AUTOANTIBODIES IN CARDIOVASCULAR DISEASES

Association of levels of HDL-cholesterol apolipoprotein CIII with the risk of coronary heart disease and cardiovascular events

Granin proteins as markers of heart disease

Monitoring myocardial infarction and its treatment

Marker for inflammatory conditions

Method and apparatus for analyzing vitamin E in lipoproteins

Method for diagnosing acute cardiac ischemia

VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR

Combined F2-isoprostane and myeloperoxidase detection, a risk indicator for cardiovascular disease